# The Treatment of Depression With Botulinum Type A Toxin

> **NCT01392963** · PHASE2 · COMPLETED · sponsor: **Seton Healthcare Family** · enrollment: 30 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** botulinum toxin type A neurotoxin complex
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01392963
- **Lead sponsor:** Seton Healthcare Family
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-11
- **Final completion:** 2013-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392963, "The Treatment of Depression With Botulinum Type A Toxin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01392963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*